These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 24972003)

  • 1. Autoantibodies in pre-clinical autoimmune disease.
    Hu ZD; Deng AM
    Clin Chim Acta; 2014 Nov; 437():14-8. PubMed ID: 24972003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
    Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
    Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cryoglobulinemia in rheumatic diseases].
    Baranauskaĭte AA; Nasonov EL; Solov'ev SK
    Klin Med (Mosk); 1991 Jun; 69(6):23-32. PubMed ID: 1774903
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA.
    Ruffatti A; Ostuni P; Grypiotis P; Botsios C; Tonello M; Grava C; Favaro M; Todesco S
    J Rheumatol; 2004 Mar; 31(3):504-7. PubMed ID: 14994395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for autoimmunity in humans.
    D'Cruz D
    Toxicol Lett; 2002 Feb; 127(1-3):93-100. PubMed ID: 12052646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
    Szántó A; Csípo I; Zeher M
    J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
    [No Abstract]   [Full Text] [Related]  

  • 8. Presymptomatic autoantibodies in Sjögren's syndrome: what significance do they hold for the clinic?
    Henriksson G
    Expert Rev Clin Immunol; 2014 Jul; 10(7):815-7. PubMed ID: 24867307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sjögren's syndrome.
    Duda S; Witte T; Stangel M; Adams J; Schmidt RE; Baerlecken NT
    Immunol Res; 2017 Dec; 65(6):1099-1102. PubMed ID: 29138979
    [No Abstract]   [Full Text] [Related]  

  • 10. Sjögren's syndrome at the crossroad of polyautoimmunity.
    Amador-Patarroyo MJ; Arbelaez JG; Mantilla RD; Rodriguez-Rodriguez A; Cárdenas-Roldán J; Pineda-Tamayo R; Guarin MR; Kleine LL; Rojas-Villarraga A; Anaya JM
    J Autoimmun; 2012 Sep; 39(3):199-205. PubMed ID: 22749530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune diseases in China.
    Li R; Sun X; Liu X; Yang Y; Li Z
    Adv Immunol; 2019; 144():173-216. PubMed ID: 31699217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases.
    Simon Q; Grasseau A; Boudigou M; Le Pottier L; Bettachioli E; Cornec D; Rouvière B; Jamin C; Le Lann L; ; ; Borghi MO; Aguilar-Quesada R; Renaudineau Y; Alarcón-Riquelme ME; Pers JO; Hillion S
    Arthritis Rheumatol; 2021 Aug; 73(8):1550-1561. PubMed ID: 33605069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autoimmune diseases.
    Condemi JJ
    JAMA; 1992 Nov; 268(20):2882-92. PubMed ID: 1433704
    [No Abstract]   [Full Text] [Related]  

  • 15. The overlap of Sjögren's syndrome with other systemic autoimmune diseases.
    Ramos-Casals M; Brito-Zerón P; Font J
    Semin Arthritis Rheum; 2007 Feb; 36(4):246-55. PubMed ID: 16996579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein.
    Coppo P; Henry-Dessailly I; Rochette J; Lok C; Buendia B; Lassoued K
    Eur J Intern Med; 2013 Dec; 24(8):868-71. PubMed ID: 24184038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?
    Cinoku I; Mavragani CP; Tellis CC; Nezos A; Tselepis AD; Moutsopoulos HM
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):61-67. PubMed ID: 30156537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
    He J; Fang W; Li ZG
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.